ACP
ORKA

Aveo Capital Partners’s Oruka Therapeutics ORKA Stock Holding History

Aveo Capital Partners’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,976
Closed -$661K – 203
2019
Q2 		$661K Buy
7,976
+7,544
+1,746% +$677K 0.29% 76
2019
Q1 		$35K Hold
432
– – 0.02% 166
2018
Q4 		$31K Hold
432
– – 0.02% 129
2018
Q3 		$58K Hold
432
– – 0.03% 138
2018
Q2 		$52K Hold
432
– – 0.02% 138
2018
Q1 		$47K Hold
432
– – 0.02% 140
2017
Q4 		$126K Hold
432
– – 0.04% 139
2017
Q3 		$107K Sell
432
-2
-0.5% -$711 0.04% 131
2017
Q2 		$225K Buy
434
+210
+94% +$110K 0.08% 109
2017
Q1 		$123K Sell
224
-849
-79% -$474K 0.05% 124
2016
Q4 		$661K Buy
+1,073
New +$571K 0.19% 82

Other funds holding ORKA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
QT
Quantamental Technologies White Plains, New York $106M AUM 22.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return